Davidson Kempner Capital Management’s Acceleron Pharma XLRN Stock Holding History

Davidson Kempner Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-140,729	Closed	-$24.2M	–	670
2021 Q3	$24.2M	Buy	+140,729	New	+$18.4M	0.35%	62

Davidson Kempner Capital Management's XLRN Position: Q4 2021 in Review

Davidson Kempner Capital Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 140,729 shares — an estimated $24.2M sold.

Davidson Kempner Capital Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $24.2M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Davidson Kempner Capital Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Davidson Kempner Capital Management sold 140,729 Acceleron Pharma shares in Q4 2021, an estimated $24.2M.
Davidson Kempner Capital Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
Davidson Kempner Capital Management's Acceleron Pharma position peaked at $24.2M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.